Literature DB >> 12059127

Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Mirjam A G Sprangers1, Carol M Moinpour, Timothy J Moynihan, Donald L Patrick, Dennis A Revicki.   

Abstract

The objective of this article is to help clinicians interpret trial-based quality of life (QOL) changes over time. We address a series of questions and provide guidelines that are fundamental to assessing and interpreting change. The issues addressed are as follows: (1) What are the characteristics of the population for whom changes in QOL are reported? (2) Is the QOL questionnaire reliable, valid, and responsive to change? (3) Are the timing and frequency of assessments adequate? (4) Is the study adequately powered? (5) How are multiple QOL outcomes addressed in analyses? (6) How are multiple time points handled? (7) Can alternative explanations account for the observed change or lack of observed change (eg, handling of missing data, survival differences, and changes in patient's QOL perspective over time)? and (8) How is statistical significance translated into meaningful change? These guidelines will support clinicians in reviewing the clinical trial literature, which in turn can help them use the data in the treatment decision process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059127     DOI: 10.4065/77.6.561

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  42 in total

1.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

2.  In reply to: Association between utility and treatment among patients with prostate cancer.

Authors:  Pranav Gandhi; Joshua Spooner; I-Chan Huang
Journal:  Qual Life Res       Date:  2010-06-26       Impact factor: 4.147

Review 3.  Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.

Authors:  Michael Brundage; Brenda Bass; Judith Davidson; John Queenan; Andrea Bezjak; Jolie Ringash; Anna Wilkinson; Deb Feldman-Stewart
Journal:  Qual Life Res       Date:  2010-11-26       Impact factor: 4.147

Review 4.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

5.  Estimating clinically significant differences in quality of life outcomes.

Authors:  Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

6.  Methods to detect response shift in quality of life data: a convergent validity study.

Authors:  Mechteld R M Visser; Frans J Oort; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

7.  Quantifying responsiveness of quality of life measures without an external criterion.

Authors:  Guang Yong Zou
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

Review 8.  The clinical significance of quality of life assessments in oncology: a summary for clinicians.

Authors:  Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol Moinpour; Mirjam Sprangers; Carol Ferrans; David Cella
Journal:  Support Care Cancer       Date:  2006-06-23       Impact factor: 3.603

9.  Placing quality of life assessments on oncologists' agenda.

Authors:  Luzia Travado
Journal:  Support Care Cancer       Date:  2006-08-26       Impact factor: 3.603

10.  Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Authors:  John D Whited; Erin M Warshaw; Karen E Edison; Kush Kapur; Lizy Thottapurathu; Srihari Raju; Bethany Cook; Holly Engasser; Samantha Pullen; Patricia Parks; Tom Sindowski; Danuta Motyka; Rodney Brown; Thomas E Moritz; Santanu K Datta; Mary-Margaret Chren; Lucinda Marty; Domenic J Reda
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.